TrialAIDS (London, England)2018

A week-48 randomized phase-3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients.

Joseph J Eron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.